| Makale Türü |
|
||
| Dergi Adı | Respiratory Research (Q1) | ||
| Dergi ISSN | 1465-9921 Dergi Bilgileri (2022) | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 09-2022 |
| Cilt / Sayı / Sayfa | 23 / 1 / 11–0 | DOI | 10.1186/s12931-022-02172-w |
| Makale Linki | https://respiratory-research.biomedcentral.com/counter/pdf/10.1186/s12931-022-02172-w | ||
| UAK Araştırma Alanları |
Tıbbi Farmakoloji
|
||
| Özet |
| BackgroundAcute respiratory distress syndrome (ARDS) is a life-threatening disease caused by the induction of inflammatory cytokines and chemokines in the lungs. There is a dearth of drug applications that can be used to prevent cytokine storms in ARDS treatment. This study was designed to investigate the effects of tocilizumab and dexamethasone on oxidative stress, antioxidant parameters, and cytokine storms in acute lung injury caused by oleic acid in rats.MethodsAdult male rats were divided into five groups: the CN (healthy rats, n = 6), OA (oleic acid administration, n = 6), OA + TCZ-2 (oleic acid and tocilizumab at 2 mg/kg, n = 6), OA + TCZ-4 (oleic acid and tocilizumab at 4 mg/kg, n = 6), and OA + DEX-10 (oleic acid and dexamethasone at 10 mg/kg, n = 6) groups. All animals were euthanized after treatment for histopathological, immunohistochemical, biochemical, PCR, and SEM analyses … |
| Anahtar Kelimeler |
| ARDS | Dexamethasone | Oleic acid | Rat | Tocilizumab |
| Atıf Sayıları | |
| Web of Science | 29 |
| Scopus | 26 |
| Google Scholar | 32 |
| Dergi Adı | RESPIRATORY RESEARCH |
| Kısa Adı | RESP RES |
| Yayıncı | BMC |
| Açık Erişim | Evet |
| ISSN | 1465-9921 |
| E-ISSN | 1465-993X |
| Wos Quartile | Q1 |
| Scopus Quartile | Q1 |
| Tarandığı Indeksler | SCIE , Scopus |
| WoS Kategoriler | RESPIRATORY SYSTEM |
| Scopus Kategoriler | PULMONARY AND RESPIRATORY MEDICINE |